Literature DB >> 30465801

Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters.

Kevin G Mulvihill1.   

Abstract

The signaling dynamics of the neurotransmitter dopamine has been established to have an important role in a variety of behavioural processes including motor control, cognition, and emotional processing. Key regulators of transmitter release and the signaling dynamics of dopamine are the plasma membrane reuptake transporter (DAT) and the vesicular monoamine transporter (VMAT2). These proteins serve to remove dopamine molecules from the extracellular and cytosolic space, respectively and both determine the amount of transmitter released from synaptic vesicles. This review provides an overview of how these transporter proteins are involved in molecular regulation and function together to govern the dynamics of vesicular release with opposing effects on the quantal size and extracellular concentration of dopamine. These transporter proteins are both focal points of convergence for a variety of regulatory molecular cascades as well as targets for many pharmacological agents. The ratio between these transporters is argued to be useful as a molecular marker for delineating dopamine functional subsystems that may differ in transmitter release patterns.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dopamine; Dopamine transporter; Quantal size; Vesicular monoamine transporter-2; Vesicular transmitter release

Mesh:

Substances:

Year:  2018        PMID: 30465801     DOI: 10.1016/j.neuint.2018.11.004

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  11 in total

Review 1.  Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease.

Authors:  Roger L Albin; Sygrid van der Zee; Teus van Laar; Martin Sarter; Cindy Lustig; Martijn L T M Muller; Nicolaas I Bohnen
Journal:  Prog Brain Res       Date:  2022-02-04       Impact factor: 2.453

Review 2.  Molecular Imaging of the Dopamine Transporter.

Authors:  Giovanni Palermo; Roberto Ceravolo
Journal:  Cells       Date:  2019-08-10       Impact factor: 6.600

3.  The SLC6A3 gene polymorphism is related to the development of attentional functions but not to ADHD.

Authors:  Katarzyna Kuc; Maksymilian Bielecki; Ewa Racicka-Pawlukiewicz; Michał B Czerwinski; Anita Cybulska-Klosowicz
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

4.  DOPA Homeostasis by Dopamine: A Control-Theoretic View.

Authors:  Rune Kleppe; Qaiser Waheed; Peter Ruoff
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

5.  Stable expression of the human dopamine transporter in N27 cells as an in vitro model for dopamine cell trafficking and metabolism.

Authors:  B S Cagle; M L Sturgeon; J B O'Brien; J C Wilkinson; R A Cornell; D L Roman; J A Doorn
Journal:  Toxicol In Vitro       Date:  2021-07-05       Impact factor: 3.685

6.  A Neurodevelopmental Model of Combined Pyrethroid and Chronic Stress Exposure.

Authors:  Aimée I Vester; Merry Chen; Carmen J Marsit; W Michael Caudle
Journal:  Toxics       Date:  2019-05-02

Review 7.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

8.  Involvement of the Catecholamine Pathway in Glioblastoma Development.

Authors:  Zoltán Kraboth; Bela Kajtár; Bence Gálik; Attila Gyenesei; Attila Miseta; Bernadette Kalman
Journal:  Cells       Date:  2021-03-04       Impact factor: 6.600

9.  Influence of Dopamine on Fluorescent Advanced Glycation End Products Formation Using Drosophila melanogaster.

Authors:  Ana Filošević Vujnović; Katarina Jović; Emanuel Pištan; Rozi Andretić Waldowski
Journal:  Biomolecules       Date:  2021-03-17

10.  (+)-9-Trifluoroethoxy-α-Dihydrotetrabenazine as a Highly Potent Vesicular Monoamine Transporter 2 Inhibitor for Tardive Dyskinesia.

Authors:  Wenyan Wang; Guangying Du; Shilan Lin; Jing Liu; Huijie Yang; Dawei Yu; Liang Ye; Fangxia Zou; Hongbo Wang; Rui Zhang; Jingwei Tian
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.